Glycated albumin activates PAI-1 transcription through Smad DNA binding sites in mesangial cells

American Journal of Physiology - Renal Physiology

Volumn 287, Issue 4 56-4, 2004, Pages

  Lee, Hyun Soon ^a   Moon, Kyung Chul ^a   Song, Chi Young ^a   Kim, Bong Cho ^a   Wang, Suxia ^a   Hong, Hye Kyoung ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Amadori adducts; CAGA boxes; Diabetic nephropathy; Extracellular matrix

Indexed keywords

BOVINE SERUM ALBUMIN; COMPLEMENTARY DNA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GENOMIC DNA; GLYCOSYLATED ALBUMIN; MESSENGER RNA; PHOSPHORUS 32; PLASMINOGEN ACTIVATOR INHIBITOR 1; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN;

ARTICLE; CAGA BOX; CAGA SEQUENCE; CONSENSUS SEQUENCE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DNA BINDING; EXTRACELLULAR MATRIX; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KIDNEY DISEASE; MESANGIUM; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; WESTERN BLOTTING;

EID: 4644240602     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00034.2004     Document Type: Article

References (46)

1. Blechova R and Pivodoa D. LAL test - an alternative method of detection of bacterial endotoxins. Acta Vet Brno 70: 291-296, 2001.
2. Chen S, Cohen MP, and Ziyadeh FN. Amadori-glycated albumin in diabetic nephropathy: pathophysiologic connections. Kidney Int 58, Suppl 77: S40-S44, 2000.
3. Cohen MP. Intervention strategies to prevent pathogenetic effects of glycated albumin. Arch Biochem Biophys 419: 25-30, 2003.
4. Cohen MP, Hud E, Wu VY, and Ziyadeh FN. Albumin modified by Amadori glucose adducts activates mesangial cell type IV collagen gene transcription. Mol Cell Biochem 151: 61-67, 1995.
5. Cohen MP and Ziyadeh FN. Amadori glucose adducts modulate mesangial cell growth and collagen gene expression. Kidney Int 45: 475-484, 1994.
6. Cohen MP, Ziyadeh FN, Lautenslager GT, Cohen JA, and Shearman CW. Glycated albumin stimulation of PKC-β activity is linked to increased collagen IV in mesangial cells. Am J Physiol Renal Physiol 276: F684-F690, 1999.
7. Curtiss LK and Witztum JL. A novel method for generating region-specific monoclonal antibodies to modified proteins. J Clin Invest 72: 1427-1438, 1983.
8. Datta PK, Blake MC, and Moses HL. Regulation of plasminogen activator inhibitor-1 expression by transforming growth factor-β-induced physical and functional interactions between Smads and Sp1. J Biol Chem 275: 40014-40019, 2000.
9. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, and Gauthier JM. Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type I gene. EMBO J 17: 3091-3100, 1998.
10. Fisher EJ, McLennan SV, Yue DK, and Turtle JR. High glucose reduces generation of plasmin activity by mesangial cells. Microvasc Res 53: 173-178, 1997.
11. Goldberg HJ, Scholey J, and Fantus IG. Glucosamine activates the plasminogen activator inhibitor I gene promoter through Sp1 DNA binding sites in glomerular mesangial cells. Diabetes 49: 863-871, 2000.
12. Hua X, Miller ZA, Wu G, Shi Y, and Lodish HF. Specificity in transforming growth factor β-induced transcription of the plasminogen activator inhibitor-1 gene: interactions of promoter DNA, transcription factor μE3, and Smad proteins. Proc Nat Acad Sci USA 96: 13130-13135, 1999.
13. Isono M, Chen S, Hong SW, Iglesias-de la Cruz MC, and Ziyadeh FN. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-β-induced fibronectin in mesangial cells. Biochem Biophys Res Commun 296: 1356-1365, 2002.
14. Kim YS, Kim BC, Song CY, Hong HK, Moon KC, and Lee HS. Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-β. J Lab Clin Med 138: 59-68, 2001.
15. Lee HS and Koh HI. Visualization of binding and uptake of oxidized low density lipoproteins by cultured mesangial cells. Lab Invest 71: 200-208, 1994.
16. Lee HS, Kim BC, Kim YS, Choi KH, and Chung HK. Involvement of oxidation in LDL-induced collagen gene regulation in mesangial cells. Kidney Int 50: 1582-1590, 1996.
17. Lee HS, Park SY, Moon KC, Hong HK, Song CY, and Hong SY. mRNA expression of urokinase and plasminogen activator inhibitor-1 in human crescentic glomerulonephritis. Histopathology 39: 182-188, 2001.
18. Li JH, Huang XR, Zhu HJ, Johnson R, and Lan HY. Role of TGF-β signaling in extracellular matrix production under high glucose conditions. Kidney Int 63: 2010-2019, 2003.
19. Liu X, Sun Y, Constantinescu SN, Karam E, Weinberg RA, and Lodish HF. Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc Natl Acad Sci USA 94: 10669-10674, 1997.
20. Marcus-Sekura CJ. Techniques for using antisense oligodeoxyribonucleotides to study gene expression. Anal Biochem 172: 289-295, 1988.
21. Massague J and Wotton D. Transcriptional control by TGF-β/Smad signaling. EMBO J 19: 1745-1754, 2000.
22. Miyazono K, ten Dijke P, and Heldin CH. TGF-β signaling by Smad proteins. Adv Immunol 75: 115-157, 2000.
23. Moustakas A, Souchelnytskyi S, and Heldin CH. Smad regulation in TGF-β signal transduction. J Cell Sci 114: 4359-4369, 2001.
24. 1 on gene expression. J Biol Chem 271: 16567-16572, 1996.
25. Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai Ji Heldin CH, Miyazono K, and ten Dijke P. TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 16: 5353-5362, 1997.
26. Poncelet AC, De Caestecker MP, and Schnaper HW. The transforming growth factor-β/SMAD signaling pathway is present and functional in human mesangial cells. Kidney Int 56: 1354-1365, 1999.
27. 2(I) collagen expression in human glomerular mesangial cells. J Biol Chem 276: 6983-6992, 2001.
28. Rerolle JP, Hertig A, Nguyen G, Sraer JD, and Rondeau EP. Plasminogen activator inhibitor type I is a potential target in renal fibrogenesis. Kidney Int 58: 1841-1850, 2000.
29. Rondeau E, Mougenot B, Lacave R, Peraldi MN, Kruithof EKO, and Sraer JD. Plaminogen activator inhibitor I in renal fibrin deposits of human nephropathies. Clin Nephrol 33: 55-60, 1990.
30. Sakai H, Jinde K, Suzuki D, Yagame M, and Nomoto Y. Localization of glycated proteins in the glomeruli of patients with diabetic nephropathy. Nephrol Dial Transplant II, Suppl 5: 66-71, 1996.
31. Schalkwijk CG, Ligtvoet N, Twaalfhoven H, Jager A, Blaauwgeers HGT, Schlingemann RO, Tarnow L, Parving HH, Stehouwer CDA, and van Hinsbergh VWM. Amadori albumin in type I diabetic patients. Correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes 48: 2446-2453, 1999.
32. Schreiber E, Matthias P, Müller MM, and Schaffner W. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res 17: 6419, 1989.
33. Shi Y, Wang YF, Jayaraman L, Yang H, Massague J, and Pavletich NP. Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-β signaling. Cell 94: 585-594, 1998.
34. Song CY, Kim BC, Hong HK, Kim BK, Kim YS, and Lee HS. Biphasic regulation of plasminogen activator/inhibitor by LDL in mesangial cells. Am J Physiol Renal Physiol 283: F423-F430, 2002.
35. Song CZ, Siok TE, and Gelehrter TD. Smad4/DPC4 and Smad3 mediate transforming growth factor-β (TGF-β) signaling through direct binding to a novel TGF-β-responsive element in the human plasminogen activator inhibitor-1 promoter. J Biol Chem 273: 29287-29290, 1998.
36. Stroschein SL, Wang W, and Luo K. Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor β-induced Smad-dependent transcriptional activation. J Biol Chem 274: 9431-9441, 1999.
37. Tsuchida KI, Zhu Y, Siva S, Dunn SR, and Sharma K. Role of Smad4 on TGF-β-induced extracellular matrix stimulation in mesangial cells. Kidney Int 63: 2000-2009, 2003.
38. Whitaker JR and Granum PE. An absolute method for protein determination based on difference in absorbance at 235 and 280 nm. Anal Biochem 109: 156-159, 1980.
39. 1 on plasminogen activators and plaminogen activator inhibitor-1 in renal glomerular cells. Exp Nephrol 1: 343-350, 1993.
40. Wrana JL, Attisano L, Wieser R, Ventura F, and Massague J. Mechanism of activation of the TGF-β receptor. Nature 370: 341-347, 1994.
41. Yagi K, Goto D, Hamamoto T, Takenoshita S, Kato M, and Miyazono K. Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad2 and Smad3. J Biol Chem 274: 703-709, 1999.
42. Yamamoto T, Nakamura T, Noble N, Ruoslahti E, and Border WA. Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90: 1814-1818, 1993.
43. Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B, and Kern SE. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1: 611-617, 1998.
44. Zhang Y, Feng XH, Wu RY, and Derynck R. Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 383: 168-172, 1996.
45. Zhao J, Shi W, Wang YL, Chen H, Bringas P Jr, Datto MB, Frederick JP, Wang XF, and Warburton D. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 282: L585-L593, 2002.
46. Ziyadeh FN, Han DC, Cohen JA, Guo J, and Cohen MP. Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the transforming growth factor-β system. Kidney Int 53: 631-638, 1998.